BR0108433A - sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições - Google Patents

sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições

Info

Publication number
BR0108433A
BR0108433A BRPI0108433-0A BR0108433A BR0108433A BR 0108433 A BR0108433 A BR 0108433A BR 0108433 A BR0108433 A BR 0108433A BR 0108433 A BR0108433 A BR 0108433A
Authority
BR
Brazil
Prior art keywords
flavoring
pharmaceutical compositions
mixtures
making
compositions
Prior art date
Application number
BRPI0108433-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Laman Alani
Donald P Gauwitz
Dilip Kaul
John M Lipari
Soumojeet Ghosh
Kennan C Marsh
Richard H Whelan
Vanik D Petrossian
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0108433A publication Critical patent/BR0108433A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
BRPI0108433-0A 2000-09-05 2001-09-04 sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições BR0108433A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05
PCT/US2001/027415 WO2002020057A2 (en) 2000-09-05 2001-09-04 Flavoring systems for pharmaceutical compositions and methods of making such compositions

Publications (1)

Publication Number Publication Date
BR0108433A true BR0108433A (pt) 2006-06-06

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108433-0A BR0108433A (pt) 2000-09-05 2001-09-04 sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições

Country Status (10)

Country Link
EP (1) EP1315487A2 (ja)
JP (1) JP2004522698A (ja)
AR (1) AR030715A1 (ja)
AU (1) AU2001288695A1 (ja)
BR (1) BR0108433A (ja)
CA (1) CA2417258A1 (ja)
MX (1) MXPA03001952A (ja)
PE (1) PE20020373A1 (ja)
UY (1) UY26925A1 (ja)
WO (1) WO2002020057A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
MXPA05005335A (es) * 2002-11-22 2005-07-25 Firmenich & Cie Composiciones orales las cuales enmascaran el sabor salado de las sales.
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) * 1996-06-03 1998-01-05 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
EP1315487A2 (en) 2003-06-04
AU2001288695A1 (en) 2002-03-22
PE20020373A1 (es) 2002-05-13
CA2417258A1 (en) 2002-03-14
WO2002020057A3 (en) 2002-05-10
MXPA03001952A (es) 2003-09-10
JP2004522698A (ja) 2004-07-29
WO2002020057A2 (en) 2002-03-14
UY26925A1 (es) 2002-04-26
AR030715A1 (es) 2003-09-03

Similar Documents

Publication Publication Date Title
ES2402544T3 (es) Preparación pelicular rápidamente soluble
AU2017203009B2 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
BR0211794A (pt) Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
US5902606A (en) Solid and liquid solutions of sparingly water-soluble medicinal substances
UA79196C2 (en) Intranasal formulation of rotigotine
ES2947572T3 (es) Composiciones de diferentes densidades para comprimidos multicapa de desintegración rápida
BR0108433A (pt) sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições
GB2228412A (en) Nicardipine pharmaceutical composition for parenteral administration
JP2005314413A (ja) 経口投与用医薬組成物
Zackheim Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
JP2003128583A (ja) 清涼化組成物
HUP0000125A2 (hu) Folyékony alendronátkészítmények, valamint eljárás azok előállítására
JP2002348236A (ja) 医薬液剤
US7429390B2 (en) Stable pharmaceutical compositions, processes for making the same and methods of their use
ES2392967T3 (es) Formulaciones mejoradas que contienen derivados de imidazol sustituido
BR0302523A (pt) Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease
TH51212A (th) ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว
JP2000515556A (ja) ニメスライド含有経口投与用薬剤
JP2007008852A (ja) プラバスタチンを含有する水性製剤の安定化方法
JP2004075571A (ja) 点鼻剤およびその製造方法
JP2001213764A (ja) 内服液剤
KR20030047503A (ko) 소브레롤·아세트아미노펜 복합 건조시럽제 및 액제
JPS63313734A (ja) シロツプ剤
JPS647967B2 (ja)

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.